NVN is just coming off year-end dumping, there's no new news that I'm aware of. Keeping current on biotechs is hard, especially when you don't know what the words mean -g-. Their protein technology gets respect, though, and they have a shot at a home run while Chondrex should bring positive cash flow before long. Well-managed, or so they say. Here's the thread;
exchange2000.com
George Fan is in touch with the company more than I am. Ed, in the Tracker, you have NVN on the TSE, also in the chart you have NUN.
Now that the year-end is over, I've stopped trading NVN, and likely won't take any profit under .34, might sell a third of position at .38 or .39, but will keep a fair bit in any case as it doesn't owe me anything and will do well in the medium term. Imho.
Thanks for all your work on this thread and others, Ed, it's much appreciated. .............. cheers ................ marcos |
